List of bibliographic references
Number of relevant bibliographic references: 14.
| Ident. | Authors (with country if any) | Title |
|---|
| 000114 (2013) |
Alicia Semaka [Canada] ; Chris Kay [Canada] ; Crystal N. Doty [Canada] ; Jennifer A. Collins [Canada] ; Natalie Tam [Canada] ; Michael R. Hayden [Canada] | High frequency of intermediate alleles on huntington disease‐associated haplotypes in British Columbia's general population |
| 000147 (2013) |
Sonia Franciosi [Canada] ; Yaein Shim [Canada] ; Margaret Lau [Canada] ; Michael R. Hayden [Canada] ; Blair R. Leavitt [Canada] | A systematic review and meta‐analysis of clinical variables used in Huntington disease research |
| 000148 (2013) |
| A randomized, double‐blind, placebo‐controlled trial of pridopidine in Huntington's disease |
| 000215 (2012) |
Joana M. Gil-Mohapel [Canada] | Screening of Therapeutic Strategies for Huntington's Disease in YAC128 Transgenic Mice |
| 000474 (2011) |
Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia |
| 000874 (2008) |
Manho Kim ; Soon-Tae Lee ; Kon Chu ; Seung U. Kim [Canada] | Stem cell‐based cell therapy for Huntington disease: A review |
| 000918 (2008) |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study |
| 001021 (2001) |
F. Squitieri [Italie] ; M. Cannella [Italie] ; P. Giallonardo [Italie] ; V. Maglione [Italie] ; C. Mariotti [Italie] ; M. R. Hayden [Canada] | Onset and pre-onset studies to define the Huntington’s disease natural history |
| 001376 (1999) |
M. O. Hebb [Canada] ; H. A. Robertson [Canada] | Motor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases |
| 001883 (1996) |
J. J. Claus [Pays-Bas] ; E. Mohr [Canada] | Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases |
| 001D22 (1993) |
Ananda Prasad Sen [Canada] ; Patricia Boksa [Canada] ; Rémi Quirion [Canada] | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
| 001F30 (1991) |
James S. Nagel [États-Unis, Canada] ; Masinore Ichise [États-Unis, Canada] ; B. Leonard Holman [États-Unis, Canada] | The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans |
| 002630 (1983) |
Neil Aronin [États-Unis] ; Paul E. Cooper [Canada] ; Linda J. Lorenz ; Edward D. Bird ; Stephen M. Sagar ; Susan E. Leeman ; Susan E. Martin [États-Unis] | Somatostatin is increased in the basal ganglia in Huntington disease |
| 002945 (1975) |
M. H. K. Shokeir [Canada] | Investigation on Huntington's disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "huntington"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i \
-Sk "huntington" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Checkpoint
|type= indexItem
|index= Title.i
|clé= huntington
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
